SecSonar.com

Apollomics, Inc. (APLM)

Apollomics, Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

Apollomics, Inc. (APLM) is a Biotechnology company based in US with a market capitalization of $16.5M. Revenue grew 4192.9% year-over-year and free cash flow was negative at -$10.4M. This page tracks APLM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

US · 13 employees · IPO Nov 26, 2021

Valuation

Valuation & price

$15.00 · as of May 17, 2026 · -59.1% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$31.98$17.96$3.93Jul 25Dec 25Jul 26Jul 7, 25$6.44Jul 9, 25$5.76Jul 11, 25$5.45Jul 15, 25$6.00Jul 17, 25$6.45Jul 21, 25$7.07Jul 23, 25$5.97Jul 25, 25$6.23Jul 29, 25$6.14Jul 31, 25$5.82Aug 4, 25$5.56Aug 6, 25$5.57Aug 11, 25$5.69Aug 13, 25$5.80Aug 15, 25$5.67Aug 19, 25$5.50Aug 21, 25$6.05Aug 25, 25$6.33Aug 27, 25$6.23Aug 29, 25$3.93Sep 3, 25$4.19Sep 5, 25$5.16Sep 9, 25$5.75Sep 11, 25$6.27Sep 16, 25$12.18Sep 18, 25$18.43Sep 22, 25$18.43Sep 24, 25$18.43Sep 26, 25$18.43Sep 30, 25$18.43Oct 2, 25$18.43Oct 6, 25$18.43Oct 8, 25$18.43Oct 10, 25$18.43Oct 14, 25$18.43Oct 16, 25$31.98Oct 21, 25$26.93Oct 23, 25$28.21Oct 27, 25$23.00Oct 29, 25$14.11Oct 31, 25$13.97Nov 4, 25$13.85Nov 6, 25$13.32Nov 10, 25$14.63Nov 12, 25$16.52Nov 14, 25$24.54Nov 18, 25$18.34Nov 20, 25$14.75Nov 25, 25$16.14Nov 28, 25$15.05Dec 2, 25$13.90Dec 4, 25$14.75Dec 8, 25$16.71Dec 10, 25$17.83Dec 12, 25$16.05Dec 16, 25$17.02Dec 18, 25$15.12Dec 22, 25$18.49Dec 24, 25$17.99Dec 29, 25$20.90Jan 2, 26$19.30Jan 6, 26$20.25Jan 8, 26$22.52Jan 12, 26$21.75Jan 14, 26$19.82Jan 16, 26$20.75Jan 21, 26$19.36Jan 23, 26$18.00Jan 27, 26$19.87Jan 29, 26$17.92Feb 2, 26$21.77Feb 4, 26$19.48Feb 9, 26$19.00Feb 11, 26$19.99Feb 13, 26$19.79Feb 18, 26$20.30Feb 20, 26$19.93Feb 24, 26$20.08Feb 26, 26$20.39Mar 2, 26$20.17Mar 4, 26$20.51Mar 6, 26$20.06Mar 10, 26$19.92Mar 12, 26$19.80Mar 17, 26$19.50Mar 19, 26$19.10Mar 23, 26$17.80Mar 25, 26$17.87Mar 27, 26$17.26Mar 31, 26$15.85Apr 2, 26$14.72Apr 7, 26$14.65Apr 9, 26$14.85Apr 13, 26$14.73Apr 15, 26$14.27Apr 17, 26$13.90Apr 22, 26$13.49Apr 24, 26$13.28Apr 28, 26$12.85Apr 30, 26$13.00May 4, 26$16.47May 6, 26$15.24May 8, 26$15.45May 12, 26$14.65May 14, 26$13.60May 18, 26$15.00May 20, 26$13.53May 22, 26$14.09May 28, 26$14.06Jun 1, 26$14.33Jun 3, 26$13.92Jun 5, 26$14.00Jun 9, 26$14.30Jun 11, 26$13.70Jun 15, 26$13.85Jun 17, 26$13.96Jun 22, 26$22.83Jun 24, 26$20.50Jun 26, 26$20.80Jul 2, 26$19.56
$3.9352-week range$36.65
Loading valuation history…

Fundamentals

Key fundamentals

$16.5M

Market cap

4192.9%

Revenue growth (YoY)

0.0%

Gross margin

-$10.4M

Free cash flow (USD)

-$2.6M

Net debt

Net cash position

56.0%

Share dilution

0/4

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2019 → 2025

FY 2019$0.00FY 2020$1.8MFY 2021$2.0KFY 2022$323.0KFY 2023$821.0KFY 2024$198.0KFY 2025$8.5M
$0$8.5M

Free cash flow by year

2019 → 2025

FY 2019$-22.8MFY 2020$-35.8MFY 2021$-43.4MFY 2022$-43.2MFY 2023$-43.2MFY 2024$-28.8MFY 2025$-10.4M
-$22.8M-$10.4M

Gross margin by year

2021 → 2025

FY 2021100.0%FY 2022100.0%FY 2023100.0%FY 2024100.0%FY 20250.0%
100.0%0.0%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed Apr 27, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingRegulatory UpdateJun 24, 2026Filing
  • Annual reportAnnual Report FiledApr 27, 2026Filing
  • Annual report20-F FiledApr 24, 2026Filing
  • 6-K filingConvertible Promissory NoteApr 1, 2026Filing

Questions

Frequently asked questions

What is Apollomics, Inc.'s market cap?

Apollomics, Inc. (APLM) has a market capitalization of $16.5M.

What is APLM's P/E ratio?

A meaningful P/E ratio is not available for APLM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying APLM stock?

SEC Form 4 filings show no open-market insider buys at Apollomics, Inc. in the last 90 days (0 sells).

Same arena

Related companies in Biotechnology

MRKR

Marker Therapeutics, Inc.

$17M

PTHS

Pelthos Therapeutics Inc.

$17.2M

LGVN

Longeveron Inc.

$15.4M

GRDX

GridAI Technologies Corp.

$18.4M

PSTV

Plus Therapeutics, Inc.

$14.4M

TAOX

TAO Synergies Inc.

$14M

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.